Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf ...

LOS ANGELES, CA / ACCESSWIRE / January 14, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...

TransMedics has previously touted its OCS as "the only FDA approved, portable, multi-organ, warm perfusion technology platform" and its NOP as providing a more efficient organ procurement process.

Olympic champion Zheng Qinwen won’t be repeating her surprising run to the Australian Open final in 2025 after a second-round ...

NDAQ:TMDX) Scott+Scott Attorneys at Law LLP Reminds Investors of Its Investigation Into TransMedics Group, Inc. (TMDX) ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ ...

TransMedics Group (TMDX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst William ...

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of TransMe ...

TransMedics Group Inc (TMDX) stock saw a decline, ending the day at $68.81 which represents a decrease of $-3.74 or -5.16% from the prior close of $72.55. The stock opened at $62.93 and touched a low ...

TransMedics faces allegations from Scorpion Capital of fraud and organ trafficking, while the company rebuffs the claims as ...

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant ...

TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today ...